A signal can arrive in many forms.
Different lab schemas, panel names, result formats, and unstructured notes make it difficult to evaluate information consistently.
Prognos Rare Disease
Find the signal.
See the care around it.
Clinically specific lab and genomic data, harmonized and enriched with patient and provider context. Give your team a clearer foundation for understanding rare disease populations and evaluating whom to engage.
What our clients say
“The Prognos Alerts program is, without doubt, the most impactful marketing lever that we can pull.”
“We were thrilled with the new data … This was a much bigger increase than we expected.”
“Prognos data is the most consistent we are seeing across all of our data vendors and overall, the program is running very smoothly.”
01 / 03
Every patient matters
Behind every rare signal is a person waiting for answers.
A lab result is more than a data point. It can help reveal a patient’s journey—and the clinicians who may help move it forward.
The data challenge
Small populations.
Complex data. Important distinctions.
When each relevant patient matters, the usefulness of a record depends on the detail and context your team can bring to it.
A finding needs its meaning.
Variant descriptions, classifications, methodology, and available phenotype information can shape how a result should be understood.
The name on the test may be one part of care.
A genetic counselor or ordering clinician may be listed on the lab record. Additional provider context can help teams evaluate the wider care network.
Coverage that connects
Broader visibility.
Fewer blind spots.
Rare disease signals are dispersed across the testing landscape. A single source can leave important gaps.
Prognos brings together data from national, specialty, regional, and academic lab relationships—then harmonizes and enriches it to help teams evaluate relevant patients and providers across sources.
01Reach across sources
Expand the view beyond one lab or feed.
02Count with confidence
De-duplicate linked records across participating data.
03Keep clinical meaning
Preserve the detail that makes a rare signal useful.
U.S. lab data networkConnected insight
Connected around your question.
Clinical depth, made usable
Bring the result into
a more complete picture.
Explore the information that can support your cohort definition, patient understanding, and provider evaluation.
01 / CLINICAL SIGNAL
Start with the result that matters.
Define your population around the tests, biomarkers, or genetic findings relevant to your question. Evaluate the result together with available assay and methodology context.
Relevant test or panelObserved resultGenetic findingAvailable assay context
Go beyond the ordering provider
A patient signal is valuable.
Provider context helps you use it.
Finding a relevant lab result is a starting point. Your team may also need to understand the specialists and other HCPs connected to the patient’s journey.
Prognos Care Team adds linked patient and provider context to expand visibility beyond the lab record and help your team assess whom to engage.
Explore Care TeamOn the lab recordProvider listed on the test
+ linked patient activity
+ available provider context
+ available provider context
Published program example · Rare skeletal dysplasia
Look beyond the raw count.
Evaluate the provider connection.
A pharmaceutical company launching a therapy for a rare skeletal dysplasia evaluated lab-based patient finding alongside its specialist criteria.
Prognos identified 13 patients and 13 unique HCPs. Eight HCPs met the client’s Provider of Interest criteria.
The comparison source reported 20 patients, with three linked to Providers of Interest. The distinction was the provider relevance behind the identified population.
Providers of Interest identified
Based on the client’s specialist criteria
13Patients identified by Prognos
13Unique HCPs linked by Prognos
Built for the work after identification
Clinical meaning.
Consistent structure.
Delivery around your workflow.
Prognos brings clinical interpretation, harmonization, and enrichment to the data foundation—then aligns the delivery format and refresh cadence to the program.
Support commercial planning, HEOR, Medical Affairs, and research with data scoped to the question and permitted use.
Already licensing data?
Make it work together
with Prognos Fusion.
Fusion brings participating licensed lab and claims sources into one harmonized, enriched feed, including eligible data your organization already licenses.
Extend available clinical and Care Team context across sources so teams can work from a consistent foundation.
Explore FusionRare Disease Patient Finder
Identify relevant patient populations using lab results, genetic findings, and available clinical detail. Add Care Team context to help evaluate the HCPs connected to those patients.
Explore Patient FinderHCP targeting & engagement
Use lab-informed intelligence to assess relevant HCPs for field, CRM, and agency workflows.
Patient journeys & evidence
Explore testing history and appropriate linked context across available patient activity.
A closer look
Your rare disease questions, answered.
What is Rare Disease Patient Finder?
Rare Disease Patient Finder helps life sciences teams identify relevant patient populations using clinically specific lab and genomic data. Work with Prognos to define the indication, tests or genes, result criteria, and delivery cadence. Care Team enrichment can add provider context to support HCP evaluation and engagement.
How do we define a rare disease population?
Start with the indication, relevant tests or genes, result criteria, available clinical attributes, and intended use. Prognos evaluates the data scope with your team before the program is defined.
Can you help identify HCPs beyond the provider on the lab record?
Care Team can add linked patient and provider context to identify additional observed HCPs and support relevance assessment. Availability depends on participating data and linkage.
Can we connect lab data we already license?
Prognos Fusion can incorporate eligible existing licensed sources within the agreed scope. Permissions, source participation, linkage, enrichment, and delivery requirements are reviewed together.
How frequently can data be delivered?
Cadence is aligned to source availability and the intended workflow. Options can include daily, twice-weekly, weekly, monthly, or one-time delivery, as agreed for the program.
Start with the rare disease question
your team needs to answer.
Explore Rare Disease Patient Finder for your indication. Bring a priority test or gene and the workflow you want to support—we’ll help define the clinical signal, provider context, and delivery approach.